Advertisement Vanc Pharmaceuticals launches first OTC product in British Columbia - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vanc Pharmaceuticals launches first OTC product in British Columbia

Vanc Pharmaceuticals has commercialized its first OTC products in British Columbia: Cortivera and Cortivera Plus for a wide range of minor skin irritations, allergic reactions and eczema.

Both products are formulated with aloe vera and Cortivera™ contains 0.5% hydrocortisone and Cortivera Plus™ contains 1% hydrocortisone.

Both are available in cream and ointment form in order to meet the specific needs of patients. The combination of aloe vera and hydrocortisone offers therapeutic benefits for skin irritations such as minor burns, allergic itch, insect bite itch, sun burn itch, eczema in addition to acting as an anti-inflammatory.

Vanc Pharmaceuticals CEO Arun Nayyar said: "We are excited to have launched the first product from our OTC portfolio and are confident in its ability to compete with the leading products in the category.

"In addition to our generic drug business which is seeing sales ramp up we have received positive feedback from pharmac